About Somalogic
Somalogic is a company based in Boulder (United States) founded in 1999 was acquired by Illumina in June 2025. Somalogic has raised $663.99 million across 20 funding rounds from investors including Société Générale, Illumina and Mitsui & Co. The company has 319 employees as of December 31, 2022. Somalogic has completed 1 acquisition, including Palamedrix. Somalogic offers products and services including SomaScan Assay, SomaScan Platform, and SomaSignal Tests. Somalogic operates in a competitive market with competitors including Nautilus Biotechnology, Amunix, Biognosys, Elektrofi and ProteinSimple, among others.
- Headquarter Boulder, United States
- Employees 319 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Somalogic Operating Co., Inc.
-
Annual Revenue
$97.67 M (USD)20as on Dec 31, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$663.99 M (USD)
in 20 rounds
-
Latest Funding Round
$211.97 M (USD), Series E
Dec 23, 2020
-
Investors
Société Générale
& 26 more
-
Employee Count
319
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Illumina
(Jun 23, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Somalogic
Somalogic offers a comprehensive portfolio of products and services, including SomaScan Assay, SomaScan Platform, and SomaSignal Tests.
High-plex assay for measuring thousands of proteins from small samples.
Platform for discovery and validation in life sciences research.
Tests for identifying biomarkers in various diseases.
People of Somalogic
Unlock access to complete
Unlock access to complete
Funding Insights of Somalogic
Somalogic has successfully raised a total of $663.99M across 20 strategic funding rounds. The most recent funding activity was a Series E round of $211.97 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Somalogic
Somalogic has secured backing from 27 investors, including venture fund and institutional investors. Prominent investors backing the company include Société Générale, Illumina and Mitsui & Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Private equity fund focused on the biotechnology sector
|
Locked | Locked | Locked | |
|
US-focused private equity and venture capital investments are managed.
|
Locked | Locked | Locked |
Investor details for Somalogic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Somalogic
Somalogic has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Palamedrix.
Investment portfolio details for Somalogic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of a multi-omics platform for therapeutics and diagnostics
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Somalogic
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Somalogic
Detailed financials for Somalogic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Somalogic Comparisons
Peer comparison for Somalogic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Somalogic
Somalogic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nautilus Biotechnology, Amunix, Biognosys, Elektrofi and ProteinSimple, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A proteomics platform is developed for analyzing the human proteome.
|
|
| Locked | Locked | Locked |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| Locked | Locked | Locked |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| Locked | Locked | Locked |
Digital platform transforming the delivery of biologic medicines
|
|
| Locked | Locked | Locked |
Provider tools to help researchers with protein analysis
|
Detailed competitors of Somalogic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Somalogic
Complete news archive for Somalogic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Somalogic
Somalogic was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Somalogic is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Somalogic is a funded company, having raised a total of $663.99M across 20 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Somalogic is 319.
Annual revenue of Somalogic is $97.67M as on Dec 31, 2022.
Somalogic was founded in 1999 and is based in Boulder, United States. Operations focus on the biotechnology sector, where proprietary SOMAmer reagentsprotein-binding molecules akin to aptamers and antibodiesare utilized in the SOMAscan assay for measuring multiple proteins. The platform is provided as reagents and kits to researchers. Future plans include laboratory-developed tests from a CLIA-certified lab and therapeutics derived from SOMAmer technology.
Somalogic's top competitors include Nautilus Biotechnology, Elektrofi and Biognosys.
Somalogic offers SomaScan Assay, SomaScan Platform, and SomaSignal Tests.
Somalogic has made 1 acquisition, including Palamedrix.
Somalogic has 27 investors. Key investors include Société Générale, Illumina, Mitsui & Co, Novartis, and Quest Diagnostics.